Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Hepatic Encepahlopathy

PTU-082 Real world impact of rifaximin-Αlpha use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: a post-hoc analysis of the impress study
M Hudson, P Di Maggio, R Cipelli, R Aspinall

Gut Jul 2017, 66 (Suppl 2) A92; DOI: 10.1136/gutjnl-2017-314472.178
PTU-102 Acute decompensated liver cirrhosis: are we bundling or bungling: our data from 2014 and 2016
O Adeloye, T Butler, K Patel, E Donaldson

Gut Jul 2017, 66 (Suppl 2) A101-A102; DOI: 10.1136/gutjnl-2017-314472.197
PWE-070 Rifaximin-Αlpha is associated with reductions in emergency department resource use in uk patients with hepatic encephalopathy: real world evidence from the impress study
M Hudson, P Di Maggio, R Cipelli, R Aspinall

Gut Jul 2017, 66 (Suppl 2) A161-A162; DOI: 10.1136/gutjnl-2017-314472.316